Market Cap 124.71M
Revenue (ttm) 56.13M
Net Income (ttm) -14.67M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -26.14%
Debt to Equity Ratio 1.24
Volume 80,500
Avg Vol 58,496
Day's Range N/A - N/A
Shares Out 20.89M
Stochastic %K 56%
Beta 0.90
Analysts Strong Sell
Price Target $9.70

Latest News on DERM

Journey Medical Corporation (DERM) Q1 2024 Earnings Call Transcript

May 13, 2024, 10:43 PM EDT - 11 months ago

Journey Medical Corporation (DERM) Q1 2024 Earnings Call Transcript


Journey Medical Corp (DERM) Q1 2023 Earnings Call Transcript

May 22, 2023, 6:50 PM EDT - 2 years ago

Journey Medical Corp (DERM) Q1 2023 Earnings Call Transcript